Juvenile Psoriatic Arthritis
📧 Sign up to get email alerts when something new happens for Juvenile Psoriatic Arthritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-07-31Clinical Trial Update: A Study of Ustekinumab or Guselkumab in Pediatric Participants With Active Juvenile Psoriatic Arthritis [Phase 3]
Phase 3 study comparing ustekinumab versus guselkumab in pediatric participants with active juvenile psoriatic arthritis has completed.
-
CLINICAL_TRIALS trial_result · 2026-06-05Clinical Trial Update: A Study of Ustekinumab or Guselkumab in Pediatric Participants With Active Juvenile Psoriatic Arthritis [Phase 3]
Phase 3 trial update evaluating ustekinumab or guselkumab in pediatric active juvenile psoriatic arthritis; status active not recruiting.
-
CLINICAL_TRIALS trial_result · 2026-02-11Clinical Trial Update: Transition to Adulthood Through Coaching and Empowerment in Rheumatology [NA]
A completed study evaluating a coaching and empowerment program to help youths with juvenile rheumatic diseases transition to adulthood.
-
CLINICAL_TRIALS trial_result · 2025-06-05Clinical Trial Update: A Study of Ixekizumab (LY2439821) in Children With Juvenile Idiopathic Arthritis Categories of Enthesitis-related Arthritis (Including Juvenile Onset Ankylosing Spondylitis) and Juvenile Psoriatic Arthritis [Phase 3]
Phase 3 study of ixekizumab in children with juvenile idiopathic arthritis subtypes Enthesitis-related Arthritis and Juvenile Psoriatic Arth…
-
CLINICAL_TRIALS trial_result · 2025-05-23Clinical Trial Update: An Extension Study of Subcutaneous Secukinumab in Patients With Juvenile Psoriatic Arthritis (JPsA) and Enthesitis Related Arthritis (ERA) [Phase 3]
This is a Phase 3 extension study of subcutaneous secukinumab in children with Juvenile Psoriatic Arthritis and Enthesitis-related Arthritis…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-04-27Clinical Trial Update: A Study of Ustekinumab in Pediatric Participants (U-POPS) With Juvenile Psoriatic Arthritis or Psoriasis [Phase 1]
Phase 1 study of ustekinumab in pediatric participants with Juvenile Psoriatic Arthritis or psoriasis has completed.
-
CLINICAL_TRIALS trial_result · 2022-08-15Clinical Trial Update: Secukinumab Safety and Efficacy in Juvenile Psoriatic Arthritis (JPsA) and Enthesitis-related Arthritis (ERA) [Phase 3]
Phase 3 trial update evaluating secukinumab for safety and efficacy in Juvenile Psoriatic Arthritis and Enthesitis-related Arthritis has com…